PMC:7408073 / 103474-103687 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T21","span":{"begin":45,"end":49},"obj":"Body_part"}],"attributes":[{"id":"A21","pred":"fma_id","subj":"T21","obj":"http://purl.org/sig/ont/fma/fma25000"}],"text":"Regarding renin inhibitors, aliskiren is the sole compound in this class of drugs that was approved by the US Food and Drug Administration in March 2007 and commercialized for the management of hypertension [186]."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"3574","span":{"begin":10,"end":15},"obj":"Gene"},{"id":"3591","span":{"begin":194,"end":206},"obj":"Disease"}],"attributes":[{"id":"A3574","pred":"tao:has_database_id","subj":"3574","obj":"Gene:5972"},{"id":"A3591","pred":"tao:has_database_id","subj":"3591","obj":"MESH:D006973"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Regarding renin inhibitors, aliskiren is the sole compound in this class of drugs that was approved by the US Food and Drug Administration in March 2007 and commercialized for the management of hypertension [186]."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T563","span":{"begin":194,"end":206},"obj":"Disease"}],"attributes":[{"id":"A563","pred":"mondo_id","subj":"T563","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"}],"text":"Regarding renin inhibitors, aliskiren is the sole compound in this class of drugs that was approved by the US Food and Drug Administration in March 2007 and commercialized for the management of hypertension [186]."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T25987","span":{"begin":16,"end":26},"obj":"Chemical"},{"id":"T36125","span":{"begin":28,"end":37},"obj":"Chemical"},{"id":"T21","span":{"begin":76,"end":81},"obj":"Chemical"}],"attributes":[{"id":"A36653","pred":"chebi_id","subj":"T25987","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A63047","pred":"chebi_id","subj":"T36125","obj":"http://purl.obolibrary.org/obo/CHEBI_601027"},{"id":"A49616","pred":"chebi_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Regarding renin inhibitors, aliskiren is the sole compound in this class of drugs that was approved by the US Food and Drug Administration in March 2007 and commercialized for the management of hypertension [186]."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T506","span":{"begin":0,"end":213},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Regarding renin inhibitors, aliskiren is the sole compound in this class of drugs that was approved by the US Food and Drug Administration in March 2007 and commercialized for the management of hypertension [186]."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T165","span":{"begin":194,"end":206},"obj":"Phenotype"}],"attributes":[{"id":"A165","pred":"hp_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":"Regarding renin inhibitors, aliskiren is the sole compound in this class of drugs that was approved by the US Food and Drug Administration in March 2007 and commercialized for the management of hypertension [186]."}